Former CEO of Africa Healthcare Network brings extensive understanding of kidney disease to ProKidneyWINSTON-SALEM, N.C., Nov. 30, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK...
WINSTON-SALEM, N.C, Nov. 21, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) ( ProKidney or the Company ), a leading late clinical-stage cellular therapeutics company focused on...
Letko Brosseau Associates Inc. purchased a new position in shares of ProKidney Corp. (NASDAQ:PROK Free Report) during the second quarter, according to its most recent 13F filing with...
ProKidney Corp. (NASDAQ:PROK Get Free Report) major shareholder Chamath Palihapitiya sold 7,256,367 shares of the companys stock in a transaction on Sunday, November 19th. The stock...
ProKidney (NASDAQ:PROK Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.18) EPS for the quarter, missing analysts consensus estimates of...